Continuous fingolimod treatment has been linked to nasopharyngitis (34%), headache (30%), fatigue (19%) and influenza (18%).

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.